Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
EMBO J ; 36(14): 2107-2125, 2017 07 14.
Article in English | MEDLINE | ID: mdl-28637794

ABSTRACT

Ca2+-sensor proteins are generally implicated in insulin release through SNARE interactions. Here, secretagogin, whose expression in human pancreatic islets correlates with their insulin content and the incidence of type 2 diabetes, is shown to orchestrate an unexpectedly distinct mechanism. Single-cell RNA-seq reveals retained expression of the TRP family members in ß-cells from diabetic donors. Amongst these, pharmacological probing identifies Ca2+-permeable transient receptor potential vanilloid type 1 channels (TRPV1) as potent inducers of secretagogin expression through recruitment of Sp1 transcription factors. Accordingly, agonist stimulation of TRPV1s fails to rescue insulin release from pancreatic islets of glucose intolerant secretagogin knock-out(-/-) mice. However, instead of merely impinging on the SNARE machinery, reduced insulin availability in secretagogin-/- mice is due to ß-cell loss, which is underpinned by the collapse of protein folding and deregulation of secretagogin-dependent USP9X deubiquitinase activity. Therefore, and considering the desensitization of TRPV1s in diabetic pancreata, a TRPV1-to-secretagogin regulatory axis seems critical to maintain the structural integrity and signal competence of ß-cells.


Subject(s)
Gene Expression Regulation , Insulin-Secreting Cells/physiology , Proteins/metabolism , Secretagogins/metabolism , TRPV Cation Channels/metabolism , Animals , Cell Survival , Gene Expression Profiling , Humans , Mice , Mice, Knockout , Secretagogins/deficiency , Single-Cell Analysis
2.
Genes Dev ; 25(24): 2674-85, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-22190461

ABSTRACT

Use-dependent selection of optimal connections is a key feature of neural circuit development and, in the mature brain, underlies functional adaptation, such as is required for learning and memory. Activity patterns guide circuit refinement through selective stabilization or elimination of specific neuronal branches and synapses. The molecular signals that mediate activity-dependent synapse and arbor stabilization and maintenance remain elusive. We report that knockout of the activity-regulated gene cpg15 in mice delays developmental maturation of axonal and dendritic arbors visualized by anterograde tracing and diolistic labeling, respectively. Electrophysiology shows that synaptic maturation is also delayed, and electron microscopy confirms that many dendritic spines initially lack functional synaptic contacts. While circuits eventually develop, in vivo imaging reveals that spine maintenance is compromised in the adult, leading to a gradual attrition in spine numbers. Loss of cpg15 also results in poor learning. cpg15 knockout mice require more trails to learn, but once they learn, memories are retained. Our findings suggest that CPG15 acts to stabilize active synapses on dendritic spines, resulting in selective spine and arbor stabilization and synaptic maturation, and that synapse stabilization mediated by CPG15 is critical for efficient learning.


Subject(s)
Brain/growth & development , Brain/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Synapses/physiology , Animals , Axons/metabolism , Dendritic Spines/genetics , Dendritic Spines/physiology , GPI-Linked Proteins/genetics , GPI-Linked Proteins/metabolism , Learning/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurons/cytology , Synapses/genetics
3.
Nature ; 454(7206): 846-51, 2008 Aug 14.
Article in English | MEDLINE | ID: mdl-18668043

ABSTRACT

The gut-derived hormone ghrelin exerts its effect on the brain by regulating neuronal activity. Ghrelin-induced feeding behaviour is controlled by arcuate nucleus neurons that co-express neuropeptide Y and agouti-related protein (NPY/AgRP neurons). However, the intracellular mechanisms triggered by ghrelin to alter NPY/AgRP neuronal activity are poorly understood. Here we show that ghrelin initiates robust changes in hypothalamic mitochondrial respiration in mice that are dependent on uncoupling protein 2 (UCP2). Activation of this mitochondrial mechanism is critical for ghrelin-induced mitochondrial proliferation and electric activation of NPY/AgRP neurons, for ghrelin-triggered synaptic plasticity of pro-opiomelanocortin-expressing neurons, and for ghrelin-induced food intake. The UCP2-dependent action of ghrelin on NPY/AgRP neurons is driven by a hypothalamic fatty acid oxidation pathway involving AMPK, CPT1 and free radicals that are scavenged by UCP2. These results reveal a signalling modality connecting mitochondria-mediated effects of G-protein-coupled receptors on neuronal function and associated behaviour.


Subject(s)
Agouti-Related Protein/metabolism , Ghrelin/metabolism , Ion Channels/metabolism , Mitochondrial Proteins/metabolism , Neurons/metabolism , Neuropeptide Y/metabolism , Reactive Oxygen Species/metabolism , Agouti-Related Protein/genetics , Animals , Carnitine O-Palmitoyltransferase/metabolism , Fatty Acids/metabolism , Feeding Behavior/drug effects , Gene Expression Regulation/drug effects , Ghrelin/pharmacology , Hypothalamus/drug effects , Hypothalamus/metabolism , Ion Channels/genetics , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/physiology , Mice , Mitochondria/drug effects , Mitochondria/physiology , Mitochondrial Proteins/genetics , Neurons/drug effects , Neuropeptide Y/genetics , Phosphorylation/drug effects , Synapses/drug effects , Synapses/metabolism , Uncoupling Protein 2
4.
J Neurosci ; 32(42): 14775-93, 2012 Oct 17.
Article in English | MEDLINE | ID: mdl-23077062

ABSTRACT

Diffuse white matter injury (DWMI) caused by hypoxia is associated with permanent neurodevelopmental disabilities in preterm infants. The cellular and molecular mechanisms producing DWMI are poorly defined. Using a mouse model of neonatal hypoxia, we demonstrate a biphasic effect on oligodendrocyte development, resulting in hypomyelination. Oligodendrocyte death and oligodendrocyte progenitor cell (OPC) proliferation during the week after hypoxia were followed by delayed oligodendrocyte differentiation and abnormal myelination, as demonstrated by electron microscopy. Cdk2 activation was essential for the regenerative OPC response after hypoxia and was accompanied by reduced FoxO1-dependent p27(Kip1) expression. p27(Kip1) was also reduced in OPCs in human infant white matter lesions after hypoxia. The negative effects of hypoxia on oligodendrogenesis and myelination were more pronounced in p27(Kip1)-null mice; conversely, overexpression of FoxO1 or p27(Kip1) in OPCs after hypoxia promoted oligodendrogenesis. Our studies demonstrate for the first time that neonatal hypoxia affects the Foxo1/p27(Kip1) pathway during white matter development. We also show that molecular manipulation of this pathway enhances oligodendrocyte regeneration during a critical developmental time window after DWMI. Thus, FoxO1 and p27(Kip1) may serve as promising target molecules for promoting timely oligodendrogenesis in neonatal DWMI.


Subject(s)
Cell Differentiation/physiology , Cyclin-Dependent Kinase Inhibitor p27/biosynthesis , Forkhead Transcription Factors/physiology , Gene Expression Regulation, Developmental , Hypoxia, Brain/metabolism , Nerve Regeneration/physiology , Oligodendroglia/physiology , Animals , Animals, Newborn , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p27/genetics , Forkhead Box Protein O1 , Humans , Hypoxia, Brain/pathology , Infant , Infant, Newborn , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Oligodendroglia/cytology
5.
Proc Natl Acad Sci U S A ; 107(33): 14875-80, 2010 Aug 17.
Article in English | MEDLINE | ID: mdl-20679202

ABSTRACT

The neuronal circuits involved in the regulation of feeding behavior and energy expenditure are soft-wired, reflecting the relative activity of the postsynaptic neuronal system, including the anorexigenic proopiomelanocortin (POMC)-expressing cells of the arcuate nucleus. We analyzed the synaptic input organization of the melanocortin system in lean rats that were vulnerable (DIO) or resistant (DR) to diet-induced obesity. We found a distinct difference in the quantitative and qualitative synaptology of POMC cells between DIO and DR animals, with a significantly greater number of inhibitory inputs in the POMC neurons in DIO rats compared with DR rats. When exposed to a high-fat diet (HFD), the POMC cells of DIO animals lost synapses, whereas those of DR rats recruited connections. In both DIO rats and mice, the HFD-triggered loss of synapses on POMC neurons was associated with increased glial ensheathment of the POMC perikarya. The altered synaptic organization of HFD-fed animals promoted increased POMC tone and a decrease in the stimulatory connections onto the neighboring neuropeptide Y (NPY) cells. Exposure to HFD was associated with reactive gliosis, and this affected the structure of the blood-brain barrier such that the POMC and NPY cell bodies and dendrites became less accessible to blood vessels. Taken together, these data suggest that consumption of an HFD has a major impact on the cytoarchitecture of the arcuate nucleus in vulnerable subjects, with changes that might be irreversible due to reactive gliosis.


Subject(s)
Diet , Gliosis/metabolism , Melanocortins/metabolism , Obesity/metabolism , Synapses/metabolism , Animals , Arcuate Nucleus of Hypothalamus/metabolism , Arcuate Nucleus of Hypothalamus/pathology , Arcuate Nucleus of Hypothalamus/physiopathology , Dietary Fats/adverse effects , Female , Gliosis/etiology , Hypothalamus/metabolism , Hypothalamus/pathology , Hypothalamus/physiopathology , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Electron , Neurons/metabolism , Neurons/ultrastructure , Neuropeptide Y/metabolism , Obesity/etiology , Pro-Opiomelanocortin/metabolism , Rats , Rats, Sprague-Dawley , Synaptic Transmission/physiology
6.
J Neurosci ; 30(2): 703-13, 2010 Jan 13.
Article in English | MEDLINE | ID: mdl-20071535

ABSTRACT

Increased sensory input from maternal care attenuates neuroendocrine and behavioral responses to stress long term and results in a lifelong phenotype of resilience to depression and improved cognitive function. Whereas the mechanisms of this clinically important effect remain unclear, the early, persistent suppression of the expression of the stress neurohormone corticotropin-releasing hormone (CRH) in hypothalamic neurons has been implicated as a key aspect of this experience-induced neuroplasticity. Here, we tested whether the innervation of hypothalamic CRH neurons of rat pups that received augmented maternal care was altered in a manner that might promote the suppression of CRH expression and studied the cellular mechanisms underlying this suppression. We found that the number of excitatory synapses and the frequency of miniature excitatory synaptic currents onto CRH neurons were reduced in "care-augmented" rats compared with controls, as were the levels of the glutamate vesicular transporter vGlut2. In contrast, analogous parameters of inhibitory synapses were unchanged. Levels of the transcriptional repressor neuron-restrictive silencer factor (NRSF), which negatively regulates Crh gene transcription, were markedly elevated in care-augmented rats, and chromatin immunoprecipitation demonstrated that this repressor was bound to a cognate element (neuron-restrictive silencing element) on the Crh gene. Whereas the reduced excitatory innervation of CRH-expressing neurons dissipated by adulthood, increased NRSF levels and repression of CRH expression persisted, suggesting that augmented early-life experience reprograms Crh gene expression via mechanisms involving transcriptional repression by NRSF.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Gene Expression Regulation, Developmental/physiology , Maternal Deprivation , Neurons/metabolism , Paraventricular Hypothalamic Nucleus/cytology , Stress, Psychological/pathology , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Chromatin Immunoprecipitation/methods , Corticotropin-Releasing Hormone/genetics , Excitatory Amino Acid Antagonists/pharmacology , Female , Male , Microscopy, Electron, Transmission/methods , Neurons/ultrastructure , Paraventricular Hypothalamic Nucleus/ultrastructure , Patch-Clamp Techniques , Physical Stimulation , Pregnancy , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Repressor Proteins/metabolism , Sodium Channel Blockers/pharmacology , Stress, Psychological/metabolism , Synaptic Potentials/drug effects , Synaptic Potentials/physiology , Tetrodotoxin/pharmacology , Vesicular Glutamate Transport Protein 2/metabolism
7.
J Neurosci ; 30(35): 11815-25, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20810901

ABSTRACT

Sirt1 has been associated with various effects of calorie restriction, including an increase in lifespan. Here we show in mice that a central regulatory component in energy metabolism, the hypothalamic melanocortin system, is affected by Sirt1, which promotes the activity and connectivity of this system resulting in negative energy balance. In adult mice, the pharmacological inhibition of brain Sirt1 activity decreased Agrp neuronal activity and the inhibitory tone on the anorexigenic POMC neurons, as measured by the number of synaptic inputs to these neurons. When a Sirt1 inhibitor (EX-527) was injected either peripherally (i.p., 10 mg/kg) or directly into the brain (i.c.v., 1.5 nmol/mouse), it decreased both food intake during the dark cycle and ghrelin-induced food intake. This effect on feeding is mediated by upstream melanocortin receptors, because the MC4R antagonist, SHU9119, reversed Sirt1's effect on food intake. This action of Sirt1 required an appropriate shift in the mitochondrial redox state: in the absence of such an adaptation enabled by the mitochondrial protein, UCP2, Sirt1-induced cellular and behavioral responses were impaired. In accordance with the pharmacological results, the selective knock-out of Sirt1 in hypothalamic Agrp neurons through the use of Cre-Lox technology decreased electric responses of Agrp neurons to ghrelin and decreased food intake, leading to decreased lean mass, fat mass, and body weight. The present data indicate that Sirt1 has a central mode of action by acting on the NPY/Agrp neurons to affect body metabolism.


Subject(s)
Agouti-Related Protein/physiology , Energy Metabolism/physiology , Melanocortins/physiology , Neuronal Plasticity/physiology , Neurons/physiology , Sirtuin 1/physiology , Synapses/physiology , Synaptic Potentials/physiology , Agouti-Related Protein/biosynthesis , Animals , Carbazoles/administration & dosage , Drug Combinations , Eating/drug effects , Eating/physiology , Energy Metabolism/drug effects , Female , Male , Melanocortins/metabolism , Melanocyte-Stimulating Hormones/administration & dosage , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Mitochondria/drug effects , Mitochondria/physiology , Neuronal Plasticity/drug effects , Neurons/drug effects , Neurons/metabolism , Oxidation-Reduction/drug effects , Sirtuin 1/antagonists & inhibitors , Sirtuin 1/deficiency , Synapses/drug effects , Synaptic Potentials/drug effects
8.
Neuron ; 51(2): 239-49, 2006 Jul 20.
Article in English | MEDLINE | ID: mdl-16846858

ABSTRACT

The neural pathways through which central serotonergic systems regulate food intake and body weight remain to be fully elucidated. We report that serotonin, via action at serotonin1B receptors (5-HT1BRs), modulates the endogenous release of both agonists and antagonists of the melanocortin receptors, which are a core component of the central circuitry controlling body weight homeostasis. We also show that serotonin-induced hypophagia requires downstream activation of melanocortin 4, but not melanocortin 3, receptors. These results identify a primary mechanism underlying the serotonergic regulation of energy balance and provide an example of a centrally derived signal that reciprocally regulates melanocortin receptor agonists and antagonists in a similar manner to peripheral adiposity signals.


Subject(s)
Eating/physiology , Neurons/physiology , Receptor, Melanocortin, Type 3/physiology , Receptor, Serotonin, 5-HT1B/physiology , Receptors, Melanocortin/physiology , Serotonin/physiology , Animals , Eating/drug effects , Electric Stimulation , Male , Mice , Mice, Inbred A , Mice, Inbred C57BL , Mice, Knockout , Mice, Obese , Mice, Transgenic , Nerve Net/drug effects , Nerve Net/physiology , Neurons/drug effects , Pyridines/pharmacology , Receptor, Melanocortin, Type 4/agonists , Receptor, Melanocortin, Type 4/antagonists & inhibitors , Receptor, Melanocortin, Type 4/physiology , Receptors, Melanocortin/agonists , Receptors, Melanocortin/antagonists & inhibitors , Serotonin/pharmacology , Serotonin 5-HT1 Receptor Agonists
9.
J Clin Invest ; 117(12): 4022-33, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18060037

ABSTRACT

Sleep is a natural process that preserves energy, facilitates development, and restores the nervous system in higher animals. Sleep loss resulting from physiological and pathological conditions exerts tremendous pressure on neuronal circuitry responsible for sleep-wake regulation. It is not yet clear how acute and chronic sleep loss modify neuronal activities and lead to adaptive changes in animals. Here, we show that acute and chronic prolonged wakefulness in mice induced by modafinil treatment produced long-term potentiation (LTP) of glutamatergic synapses on hypocretin/orexin neurons in the lateral hypothalamus, a well-established arousal/wake-promoting center. A similar potentiation of synaptic strength at glutamatergic synapses on hypocretin/orexin neurons was also seen when mice were sleep deprived for 4 hours by gentle handling. Blockade of dopamine D1 receptors attenuated prolonged wakefulness and synaptic plasticity in these neurons, suggesting that modafinil functions through activation of the dopamine system. Also, activation of the cAMP pathway was not able to further induce LTP at glutamatergic synapses in brain slices from mice treated with modafinil. These results indicate that synaptic plasticity due to prolonged wakefulness occurs in circuits responsible for arousal and may contribute to changes in the brain and body of animals experiencing sleep loss.


Subject(s)
Intracellular Signaling Peptides and Proteins , Neuronal Plasticity , Neurons/metabolism , Neuropeptides , Sleep Deprivation/metabolism , Synapses/metabolism , Wakefulness , Animals , Benzhydryl Compounds/adverse effects , Benzhydryl Compounds/pharmacology , Central Nervous System Stimulants/adverse effects , Central Nervous System Stimulants/pharmacology , Cyclic AMP/metabolism , Dopamine/metabolism , Female , Hypothalamus/metabolism , Hypothalamus/pathology , Intracellular Signaling Peptides and Proteins/metabolism , Long-Term Potentiation , Male , Mice , Modafinil , Neuronal Plasticity/drug effects , Neurons/pathology , Neuropeptides/metabolism , Orexins , Receptors, Dopamine D1/metabolism , Sleep Deprivation/chemically induced , Sleep Deprivation/pathology , Synapses/pathology , Wakefulness/drug effects
10.
J Clin Invest ; 116(12): 3229-39, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17060947

ABSTRACT

The gut hormone ghrelin targets the brain to promote food intake and adiposity. The ghrelin receptor growth hormone secretagogue 1 receptor (GHSR) is present in hypothalamic centers controlling energy metabolism as well as in the ventral tegmental area (VTA), a region important for motivational aspects of multiple behaviors, including feeding. Here we show that in mice and rats, ghrelin bound to neurons of the VTA, where it triggered increased dopamine neuronal activity, synapse formation, and dopamine turnover in the nucleus accumbens in a GHSR-dependent manner. Direct VTA administration of ghrelin also triggered feeding, while intra-VTA delivery of a selective GHSR antagonist blocked the orexigenic effect of circulating ghrelin and blunted rebound feeding following fasting. In addition, ghrelin- and GHSR-deficient mice showed attenuated feeding responses to restricted feeding schedules. Taken together, these data suggest that the mesolimbic reward circuitry is targeted by peripheral ghrelin to influence physiological mechanisms related to feeding.


Subject(s)
Appetite/drug effects , Dopamine/metabolism , Neurons/metabolism , Peptide Hormones/pharmacology , Action Potentials/drug effects , Animals , Fluorescent Antibody Technique/methods , Ghrelin , Male , Mesencephalon/cytology , Mesencephalon/drug effects , Mesencephalon/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurons/drug effects , Neurons/physiology , Nucleus Accumbens/cytology , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Patch-Clamp Techniques , Peptide Hormones/metabolism , Rats , Rats, Sprague-Dawley , Receptors, G-Protein-Coupled/metabolism , Receptors, Ghrelin , Time Factors , Ventral Tegmental Area/cytology , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/metabolism
11.
Nat Neurosci ; 8(10): 1289-91, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16158063

ABSTRACT

Multiple hormones controlling energy homeostasis regulate the expression of neuropeptide Y (NPY) and agouti-related peptide (AgRP) in the arcuate nucleus of the hypothalamus. Nevertheless, inactivation of the genes encoding NPY and/or AgRP has no impact on food intake in mice. Here we demonstrate that induced selective ablation of AgRP-expressing neurons in adult mice results in acute reduction of feeding, demonstrating direct evidence for a critical role of these neurons in the regulation of energy homeostasis.


Subject(s)
Arcuate Nucleus of Hypothalamus/cytology , Feeding Behavior/physiology , Gene Expression Regulation/physiology , Neurons/metabolism , Proteins/metabolism , Agouti-Related Protein , Animals , Anorexia/metabolism , Body Weight/drug effects , Body Weight/physiology , Cell Count/methods , Diphtheria Toxin/pharmacology , Eating/drug effects , Gene Expression Regulation/drug effects , Intercellular Signaling Peptides and Proteins , Mice , Mice, Knockout , Neurons/drug effects , Neuropeptide Y/genetics , Neuropeptide Y/metabolism , Pro-Opiomelanocortin/deficiency , Pro-Opiomelanocortin/genetics , Pro-Opiomelanocortin/metabolism , Proteins/genetics , Time Factors , beta-Galactosidase/biosynthesis
12.
JCI Insight ; 4(4)2019 02 21.
Article in English | MEDLINE | ID: mdl-30830860

ABSTRACT

GPR55, a lipid-sensing receptor, is implicated in cell cycle control, malignant cell mobilization, and tissue invasion in cancer. However, a physiological role for GPR55 is virtually unknown for any tissue type. Here, we localize GPR55 to self-renewing ductal epithelial cells and their terminally differentiated progeny in both human and mouse salivary glands. Moreover, we find GPR55 expression downregulated in salivary gland mucoepidermoid carcinomas and GPR55 reinstatement by antitumor irradiation, suggesting that GPR55 controls renegade proliferation. Indeed, GPR55 antagonism increases cell proliferation and function determination in quasiphysiological systems. In addition, Gpr55-/- mice present ~50% enlarged submandibular glands with many more granulated ducts, as well as disordered endoplasmic reticuli and with glycoprotein content. Next, we hypothesized that GPR55 could also modulate salivation and glycoprotein content by entraining differentiated excretory progeny. Accordingly, GPR55 activation facilitated glycoprotein release by itself, inducing low-amplitude Ca2+ oscillations, as well as enhancing acetylcholine-induced Ca2+ responses. Topical application of GPR55 agonists, which are ineffective in Gpr55-/- mice, into adult rodent submandibular glands increased salivation and saliva glycoprotein content. Overall, we propose that GPR55 signaling in epithelial cells ensures both the life-long renewal of ductal cells and the continuous availability of saliva and glycoproteins for oral health and food intake.


Subject(s)
Adult Stem Cells/physiology , Carcinoma, Mucoepidermoid/pathology , Cell Differentiation/physiology , Receptors, Cannabinoid/metabolism , Salivary Gland Neoplasms/pathology , Salivation/physiology , Adult , Adult Stem Cells/drug effects , Aged , Aged, 80 and over , Animals , Cannabinoid Receptor Agonists/pharmacology , Cannabinoid Receptor Antagonists/pharmacology , Carcinoma, Mucoepidermoid/radiotherapy , Cell Differentiation/drug effects , Cell Self Renewal/drug effects , Cell Self Renewal/physiology , Down-Regulation , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Female , Glycoproteins/metabolism , Humans , Male , Mice , Mice, Knockout , Middle Aged , Receptors, Cannabinoid/genetics , Saliva/chemistry , Saliva/metabolism , Salivary Gland Neoplasms/radiotherapy , Salivation/drug effects , Submandibular Gland/drug effects , Submandibular Gland/metabolism , Submandibular Gland/pathology
13.
Neuron ; 44(4): 677-90, 2004 Nov 18.
Article in English | MEDLINE | ID: mdl-15541315

ABSTRACT

Long-term maintenance and modification of synaptic strength involve the turnover of neurotransmitter receptors. Glutamate receptors are constitutively and acutely internalized, presumptively through clathrin-mediated receptor endocytosis. Here, we show that cpg2 is a brain-specific splice variant of the syne-1 gene that encodes a protein specifically localized to a postsynaptic endocytotic zone of excitatory synapses. RNAi-mediated CPG2 knockdown increases the number of postsynaptic clathrin-coated vesicles, some of which traffic NMDA receptors, disrupts the constitutive internalization of glutamate receptors, and inhibits the activity-induced internalization of synaptic AMPA receptors. Manipulating CPG2 levels also affects dendritic spine size, further supporting a function in regulating membrane transport. Our results suggest that CPG2 is a key component of a specialized postsynaptic endocytic mechanism devoted to the internalization of synaptic proteins, including glutamate receptors. The activity dependence and distribution of cpg2 expression further suggest that it contributes to the capacity for postsynaptic plasticity inherent to excitatory synapses.


Subject(s)
Brain/physiology , Endocytosis/physiology , Nerve Tissue Proteins/physiology , Receptors, Glutamate/physiology , Synapses/physiology , Animals , Base Sequence , Blotting, Northern , Blotting, Western , Cells, Cultured , Clathrin-Coated Vesicles/metabolism , Humans , In Situ Hybridization , Microscopy, Electron , Molecular Sequence Data , Neuronal Plasticity/physiology , Neurons/metabolism , Receptors, AMPA/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Synapses/ultrastructure
14.
J Neurosci ; 24(50): 11439-48, 2004 Dec 15.
Article in English | MEDLINE | ID: mdl-15601950

ABSTRACT

The hypothalamic neuropeptides hypocretins (orexins) play a crucial role in the stability of arousal and alertness. We tested whether the hypocretinergic system is a critical component of the stress response activated by the corticotropin-releasing factor (CRF). Our results show that CRF-immunoreactive terminals make direct contact with hypocretin-expressing neurons in the lateral hypothalamus and that numerous hypocretinergic neurons express the CRF-R1/2 receptors. We also demonstrate that application of CRF to hypothalamic slices containing identified hypocretin neurons depolarizes membrane potential and increases firing rate in a subpopulation of hypocretinergic cells. CRF-induced depolarization was tetrodotoxin insensitive and was blocked by the peptidergic CRF-R1 antagonist astressin. Moreover, activation of hypocretinergic neurons in response to acute stress was severely impaired in CRF-R1 knock-out mice. Together, our data provide evidence of a direct neuroanatomical and physiological input from CRF peptidergic system onto hypocretin neurons. We propose that, after stressor stimuli, CRF stimulates the release of hypocretins and that this circuit contributes to activation and maintenance of arousal associated with the stress response.


Subject(s)
Arousal/physiology , Brain Chemistry/physiology , Corticotropin-Releasing Hormone/physiology , Intracellular Signaling Peptides and Proteins/physiology , Neuropeptides/physiology , Stress, Physiological/physiopathology , Action Potentials/physiology , Animals , Brain/anatomy & histology , Corticotropin-Releasing Hormone/analysis , Female , Hypothalamus/chemistry , Hypothalamus/physiology , Immunohistochemistry , In Vitro Techniques , Intracellular Signaling Peptides and Proteins/analysis , Male , Membrane Potentials/physiology , Mice , Mice, Knockout , Neural Pathways/anatomy & histology , Neural Pathways/chemistry , Neurons/chemistry , Neurons/physiology , Neuropeptides/analysis , Orexin Receptors , Orexins , Receptors, Corticotropin-Releasing Hormone/genetics , Receptors, Corticotropin-Releasing Hormone/physiology , Receptors, G-Protein-Coupled , Receptors, Neuropeptide , Recombinant Fusion Proteins
15.
Diabetes ; 59(2): 337-46, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19933998

ABSTRACT

OBJECTIVE: The sites of insulin action in the central nervous system that regulate glucose metabolism and energy expenditure are incompletely characterized. We have shown that mice with hypothalamic deficiency (L1) of insulin receptors (InsRs) fail to regulate hepatic glucose production (HGP) in response to insulin. RESEARCH DESIGN AND METHODS: To distinguish neurons that mediate insulin's effects on HGP from those that regulate energy homeostasis, we used targeted knock-ins to express InsRs in agouti-related protein (AgRP) or proopiomelanocortin (POMC) neurons of L1 mice. RESULTS: Restoration of insulin action in AgRP neurons normalized insulin suppression of HGP. Surprisingly, POMC-specific InsR knock-in increased energy expenditure and locomotor activity, exacerbated insulin resistance and increased HGP, associated with decreased expression of the ATP-sensitive K(+) channel (K(ATP) channel) sulfonylurea receptor 1 subunit, and decreased inhibitory synaptic contacts on POMC neurons. CONCLUSIONS: The contrasting phenotypes of InsR knock-ins in POMC and AgRP neurons suggest a branched-pathway model of hypothalamic insulin signaling in which InsR signaling in AgRP neurons decreases HGP, whereas InsR activation in POMC neurons promotes HGP and activates the melanocortinergic energy expenditure program.


Subject(s)
Agouti-Related Protein/physiology , Energy Metabolism , Glucose/biosynthesis , Liver/metabolism , Neurons/physiology , Pro-Opiomelanocortin/genetics , Pro-Opiomelanocortin/physiology , Receptor, Insulin/physiology , Animals , Body Weight , DNA Primers , Energy Intake , Fasting , Glucagon/blood , Glucose Clamp Technique , Insulin/pharmacology , Mice , Mice, Transgenic , RNA/genetics , RNA/isolation & purification , Receptor, Insulin/genetics , Reverse Transcriptase Polymerase Chain Reaction
16.
Neurobiol Aging ; 28(8): 1286-95, 2007 Aug.
Article in English | MEDLINE | ID: mdl-16870307

ABSTRACT

Orexin neuropeptides regulate arousal state and excite the noradrenergic locus coeruleus (LC), so it is plausible that an age-related loss of orexin neurons and projections to the LC contributes to poor sleep quality in elderly humans and nonhuman primates. To test this hypothesis we examined orexin B-immunoreactivity in the lateral hypothalamic area (LHA) and the LC of male rhesus macaques (Macaca mulatta) throughout the life span. Orexin perikarya, localized predominantly in the LHA, showed identical distribution patterns irrespective of age. Similarly, orexin neuron number and serum orexin B concentrations did not differ with age. In contrast, orexin B-immunoreactive axon density in the LC of old animals was significantly lower than that observed in the young or adult animals. Furthermore, the age-related decline was associated with a significant decrease in tyrosine hydroxylase (TH) mRNA in the LC, despite no change in TH-immunoreactive neuron number. Taken together, these data suggest that age-related decreases in excitatory orexin innervation to the noradrenergic LC may contribute to the etiology of poor sleep quality in the elderly.


Subject(s)
Aging/physiology , Intracellular Signaling Peptides and Proteins/metabolism , Locus Coeruleus/cytology , Macaca mulatta/physiology , Neurons/metabolism , Neuropeptides/metabolism , Age Factors , Analysis of Variance , Animals , Hypothalamic Area, Lateral/metabolism , In Situ Hybridization/methods , Intracellular Signaling Peptides and Proteins/blood , Male , Neuropeptides/blood , Orexins , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL